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background:  The development of contrast-induced nephropathy (CIN) after primary percutaneous coronary intervention (pPCI) for ST-segment 
elevation myocardial infarction (STEMI) is strongly associated with increased short-term mortality. However high risk features may lead both to acute 
renal damage and to increased mortality and the independent predictive role of CIN on short- and long-term mortality is still undefined.
methods: We prospectively enrolled all consecutive STEMI patients undergoing pPCI in our centre in 2005-2012 (n=1515 after exclusion of 35 pts 
with no creatinine values after pPCI), with a mean follow-up of 876 days. CIN was defined as an increase in creatinine >25% (CIN 0.25) or >0.5mg/
dl (CIN 0.5) in the first 72 hours. Multivariable predictors of mortality were evaluated with a Cox regression.
results: CIN 0.25 occurred in 13.5% (n=209) of patients while CIN 0.5 in 5.5% (n=85). Patients with CIN were older, had more frequently anterior 
MI, a TIMI flow <3 after PCI, a higher Killip class, higher baseline creatinine, higher CK peak and lower LV ejection fraction. In univariate analysis 
CIN was significantly associated (p<0.001) with higher in-hospital mortality (9.1% vs 3.0% for CIN 0.25 and 19% vs 2.9% for CIN 0.5), higher 
long-term mortality (24.6% vs 8.9% for CIN 0.25 and 38.5% vs 9.3% for CIN 0.5). However, multivariable analysis showed that only CIN 0.5 was an 
independent predictor of in-hospital mortality (OR 2.99, 95%CI 1.15-7.80, p=0.025) and long-term mortality (OR 1.97, 95%CI 1.18-3.23,p=0.009), 
while CIN 0.25 was not associated with in-hospital mortality (OR 1.56, 95%CI 0.63-3.87) or long-term mortality (OR 1.51, 95%CI 0.97-2.36) . LV 
ejection fraction, age, CK peak and baseline haemoglobin were independent predictors of mortality in every analysis.
Conclusions: Both CIN 0.25 and CIN 0.5 are associated with higher in-hospital and long-term mortality in STEMI patients undergoing pPCI. 
However, while CIN 0.25 occurs in >10% of patients and is not an independent predictor of mortality, CIN 0.5 occurs less frequently, is likely 
expression of a more severe renal damage, and leads to a three-fold increase in in-hospital mortality and a two-fold increase in long-term mortality.
